Study of Noninvasive Gastric Focused Ultrasound Stimulation to Evaluate Effects on Gastroparesis and Delayed Gastric Emptying
Led by Evan (Huiliang) Wang · Updated on 2026-11-04
12
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether noninvasive gastric focused ultrasound stimulation affects post-meal gastric electrical activity and gastrointestinal symptoms in adults with gastroparesis or delayed gastric emptying. This pilot study uses a randomized, sham-controlled crossover design to explore physiological responses and symptom changes, aiming to assess feasibility and preliminary effects rather than clinical effectiveness.
Participants will attend two study visits in random order, receiving active gastric focused ultrasound stimulation during one visit and sham stimulation during the other. Each visit involves fasting baseline electrogastrography EGG recording, consumption of up to two bottles of a standard nutritional drink, post-meal EGG monitoring, and either active or sham stimulation delivered via an ultrasound transducer placed over the abdomen. The active stimulation lasts 600 seconds with specific ultrasound pulse parameters, while the sham visit mimics all procedures without delivering ultrasound energy.
During the study visits, participants will undergo continuous EGG monitoring before, during, and after stimulation, while gastrointestinal symptoms are assessed using the Total Symptom Score questionnaire at multiple time points. The study measures changes in gastric electrical rhythms, frequencies, amplitudes, and time spent in normal rhythm, comparing active and sham conditions within participants. Safety and tolerability will be monitored throughout, with participants able to pause or stop procedures if needed.
CONDITIONS
Brief Title
Gastric Focused Ultrasound Stimulation
Research Team
M
Mengmeng Yao, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Active gastric focused ultrasound stimulation
Sham gastric focused ultrasound stimulation
What it is
A noninvasive device using focused ultrasound applied through the abdominal skin over the stomach to deliver pulsed ultrasound stimulation (20% duty cycle, 650 kHz center frequency) for 600 seconds
A sham stimulation procedure that mimics the setup but delivers no focused ultrasound energy
Role in the trial
Investigational stimulation condition
Control (placebo) condition for crossover comparison
Primary use
To evaluate whether focused ultrasound can change postprandial gastric electrical activity and reduce gastrointestinal symptom severity in adults with gastroparesis
Serves as placebo control to assess measurement and symptom changes without active ultrasound stimulation
How it is given or performed
Participants receive active focused ultrasound via an abdominal transducer with coupling gel during a 600‑second session following a nutritional drink and electrogastrography monitoring
Participants undergo identical setup and monitoring but receive sham (inactive) stimulation during the equivalent time period
Evidence status
No published outcomes yet; trial is currently underway and results are pending
As a sham control, there is no expectation of physiological or symptom changes beyond placebo effect; evidence not available yet
Important limitations
Small pilot study with a crossover design in only 12 participants limits ability to detect uncommon effects or longer‑term outcomes
Same small sample and brief intervention period limit conclusions about sham‑adjusted effects
Patient impact
Not yet established; impact on symptoms and gastric electrical activity is under investigation
Not applicable beyond placebo control in research context
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Age 18 to 70 years
Diagnosed with delayed gastric emptying or gastroparesis confirmed by gastric emptying scintigraphy or breath test
Ability to understand study procedures and provide informed consent
Ability to complete two study visits
Ability to consume two bottles of Ensure or Glucerna nutritional drink used in the study
You will not qualify if you...
Pregnancy
Epilepsy
Cardiac pacemaker or other implanted electronic medical device
Receiving peritoneal dialysis
Daily use of narcotic or opioid medications
Abdominal wall ulcers, open wounds, active infection, or skin irritation where electrodes or ultrasound transducer will be placed
Known allergy or contraindication to Ensure or Glucerna nutritional drinks
Any medical or safety condition deemed unsafe by the study team
Use of medications affecting gastric motility or emptying within restriction period (may cause rescheduling)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Visits
Duration - 2 to 4 weeks
Participants attend two visits in random order, receiving active gastric focused ultrasound stimulation during one visit and sham stimulation during the other. Each visit includes fasting baseline and post-meal electrogastrography recordings, consumption of nutritional drinks, ultrasound procedures, and symptom assessments.
2 visits separated by at least 48 hours
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Nutritional Support Strategies for Critically Ill Adults with Impaired Gastrointestinal Function
Comparing Enteral Nutrition Alone Versus Enteral Plus Supplemental Parenteral Nutrition
Using Body Surface Gastric Mapping Device to Study Stomach Activity and Gastrointestinal Symptoms in Children and Young Adults
Use of Domperidone to Treat Children and Young Adults Aged 12 to 21 with Difficult-to-Treat Gastroparesis and GERD
Study on Enhanced Recovery After Pancreatic Surgery
Evaluating Patient Outcomes, Surgery Results, and Stress Response
A Prospective Observational Study in Greece
Creating and Testing a Risk Model for Gastric Retention in Adults Undergoing Sedated Gastroscopy Procedures
Comparing Treatment Effects of Gastric Peroral Endoscopic Pyloromyotomy and PEG-J in Adults with Refractory Gastroparesis
Study of Ultrasound and Acetaminophen Tests to Measure Stomach Emptying in Children Ages 2 to 18 Undergoing Surgery
Using Bedside Gastric Ultrasound to Evaluate How Vasopressor Dose Affects Stomach Emptying and Feeding Tolerance in Critically Ill ICU Patients
Study of Noninvasive Gastric Focused Ultrasound Stimulation to Evaluate Effects on Gastroparesis and Delayed Gastric Emptying
Comprehensive Study of Stomach Function in Adults With Type 1 or Type 2 Diabetes Mellitus
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Efficacy of needleless transcutaneous electroacupuncture in synchronization with breathing for symptomatic idiopathic gastroparesis: A blinded and controlled acute treatment trial.